Press releases

Quantum Genomics to Present at Biotech Showcase 2018

Quantum Genomics announces recruitment of first patients in the NEW-HOPE arterial hypertension study in the United States

Quantum Genomics receives the Galien MedStartUp award for the innovative design of its NEW-HOPE study

Quantum Genomics nominated for the Galien MedStartUp Award for the innovative design of its NEW-HOPE trial

Quantum Genomics Releases 2017 First-Half Financial Results and First Nine Months Business Update

Quantum Genomics to Present at Rodman and Renshaw 19th Annual Global Investment Conference

Quantum Genomics Receives FDA Clearance of IND Application for QGC001

Quantum Genomics raises EUR 8.2 Million in Europe and the U.S.

Quantum Genomics begins trading in the U.S. on OTCQX

Quantum Genomics appoints Professor Toshiro Fujita as member of its Scientific Advisory Board

Quantum Genomics announces the design of its next Phase II trial in arterial hypertension, NEW-HOPE

Quantum Genomics details positive results from its Phase IIa trial of QGC001 for the treatment of arterial hypertension

Quantum Genomics to host two upcoming events

Quantum Genomics to Host Key Opinion Leader Event Focused on Phase IIa Hypertension Data and the Upcoming Clinical Trial in the United States

Quantum Genomics will organize a teleconference on June 19, 2017, to comment on phase IIa data in high blood pressure

Quantum Genomics appoints Bruno Besse as Chief Medical Officer

2016 annual financial results and next development steps in 2017

Quantum Genomics announces positive data from new preclinical studies with QGC001

2017 financial calendar - Quantum Genomics has joined the Pass French Tech program

Quantum Genomics granted key European patent for QGC011 combination therapy program